It appears the polyphenols in coffee (not the caffeine specifically) may support the hormones activity
The Phase 2/3 LIFT-AD trial (NCT04488419), evaluating once-daily subcutaneous fosgonimeton 40 mg versus placebo in 312 participants with mild-to-moderate Alzheimers disease over 26 weeks, failed its primary endpoint (Global Statistical Test composite of ADAS-Cog11 and ADCS-ADL23) and its key secondary endpoints when results were announced in September 2024
Our team sources peptides from facilities that use small-batch synthesis with validated cold chain logistics
Your clinician will answer any questions you have and work with you to provide the recommendations you need to hit your goals
Demographic Breakdown of GLP-1 Use Data Source: IRIS by Real Chemistry | Image Credit: Real Chemistry Despite the surge in demand for GLP-1 medications, significant disparities exist when it comes to who is using them
Managing Expectations While Glutathione injections can provide significant improvements in skin tone and overall complexion, its essential to have realistic expectations regarding their permanence
